Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis-Reference-Cited by-同舟云学术

Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis

Published:2017-07 Issue:1 Volume:67 Page:92-99
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Sapisochin Gonzalo,Barry Aisling,Doherty Mark,Fischer Sandra,Goldaracena Nicolas,Rosales Roizar,Russo Moises,Beecroft Rob,Ghanekar Anand,Bhat Mamatha,Brierley James,Greig Paul D.,Knox Jennifer J.,Dawson Laura A.,Grant David R.

Publisher

Elsevier BV

Subject

Hepatology

Reference25 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Management of hepatocellular carcinoma: An update;Bruix;Hepatology,2011

3. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate;Cescon;J Hepatol,2012

4. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients;Agopian;Ann Surg,2015

5. Locoregional therapy of hepatocellular carcinoma;Habib;Clin Liver Dis,2015

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2025-01

2. Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China;Hepatobiliary & Pancreatic Diseases International;2024-09

3. Embolic and Ablative Therapy for Hepatocellular Carcinoma;Clinics in Liver Disease;2024-09

4. Multidisciplinary assessment of tumor response after internal and external radiation therapy for hepatocellular carcinoma;Hepatoma Research;2024-07-24

5. Bridge Therapy before Liver Transplant for Advanced Hepatocellular Carcinoma;Medicina;2024-06-20